Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Allovir Inc ALVR

Healthcare Biotechnology
AlloVir, Inc. is an allogeneic T cell immunotherapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The company’s proprietary technology platforms leverage off-the-shelf, allogeneic, single- and multi-virus-specific T cells for patients with T cell deficiencies who are at risk from the life... see more

Recent & Breaking News (NDAQ:ALVR)

AlloVir, Inc. Class Action: Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR

Accesswire February 29, 2024

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR

Newsfile February 29, 2024

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm

Newsfile February 29, 2024

SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In AlloVir To Contact Him Directly To Discuss Their Options

PR Newswire February 29, 2024

AlloVir, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR

Accesswire February 29, 2024

Class Action Filed Against AlloVir, Inc. (ALVR) - March 19, 2024 Deadline to Join - Contact Levi & Korsinsky

Accesswire February 29, 2024

ALVR SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds AlloVir Inc. Investors to Join the Class Action Lawsuit!

Accesswire February 29, 2024

ALLOVIR INVESTOR ALERT: Kirby McInerney LLP Notifies AlloVir, Inc. (ALVR) Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

Newsfile February 28, 2024

AlloVir Shareholder Notice

Newsfile February 28, 2024

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm

Newsfile February 28, 2024

Class Action Filed Against AlloVir, Inc. (ALVR) - March 19, 2024 Deadline to Join - Contact Levi & Korsinsky

Accesswire February 28, 2024

AlloVir, Inc. Class Action: Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR

Accesswire February 28, 2024

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of AlloVir, Inc.(ALVR) Shareholders

Accesswire February 28, 2024

DEADLINE ALERT: Bernstein Liebhard LLP Reminds AlloVir, Inc. Investors of Upcoming Deadline

Accesswire February 28, 2024

Shareholders that lost money on AlloVir, Inc.(ALVR) should contact Levi & Korsinsky about pending Class Action - ALVR

Accesswire February 28, 2024

Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR

Accesswire February 28, 2024

ALVR SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds AlloVir Inc. Investors to Join the Class Action Lawsuit!

Accesswire February 28, 2024

March 19, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ALVR

Accesswire February 28, 2024

Levi & Korsinsky Notifies Shareholders of AlloVir, Inc. (ALVR) of a Class Action Lawsuit and an Upcoming Deadline

Accesswire February 27, 2024

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm

Newsfile February 27, 2024